"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.

The Phase III Purpose 2 trial compared the safety and efficacy of twice-yearly subcutaneous lenacapavir for pre-exposure ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

Philanthropist Bill Gates, the founder and co-chair of the Bill and Melinda Gates Foundation says more lives can be saved ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

While oral PrEP is effective in curbing the risk of HIV infection, it needs to be followed consistently every day for ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results ...

Discover the groundbreaking results of Lenacapavir, a twice-yearly injection that reduces HIV infection risk offering an ...

Médecins sans frontières (MSF) to roll out injectable Human Immunodeficiency Virus (HIV) prevention drug in southern Africa ...

A twice-yearly injection of Sunlenca (lenacapavir) reduces the risk of HIV infection by 96%, which is significantly more ...